• Kiora Pharmaceuticals held its annual shareholder meeting on June 10, 2026.
• Shareholders elected Lisa Walters-Hoffert, Aron Shapiro, and Praveen Tyle to the board.
• Shareholders ratified Haskell & White LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Investors authorized an amendment to the 2024 Equity Incentive Plan, increasing shares available for issuance by 1.5 million.
• The equity plan authorization reflects approval of the amendment, not the issuance of any shares or awards.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiora Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001372514-26-000059), on June 11, 2026, and is solely responsible for the information contained therein.